Results 11 to 20 of about 1,107,300 (284)

Artificial intelligence in colorectal cancer: a review

open access: yesСибирский онкологический журнал, 2023
The study objective: the study objective is to examine the use of artificial intelligence (AI) in the diagnosis, treatment, and prognosis of Colorectal Cancer (CRC) and discuss the future potential of AI in CRC. Material and Methods.
G. Singh
doaj   +1 more source

A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis

open access: yesOpen Medicine, 2023
Colorectal cancer (CRC) is a common malignant gastrointestinal tumor. Long noncoding RNAs (lncRNAs) are revealed to be critically involved in CRC progression, providing new direction for exploring the pathogenesis of CRC.
Liao Chuanwen   +5 more
doaj   +1 more source

Expression Levels of the YAP, TAZ, and TEAD1 Hippo Pathway Genes in Colorectal Villous Adenoma Polyps [PDF]

open access: yesIranian Journal of Colorectal Research, 2022
Background Villous adenoma polyps are mostly considered to associate with a high risk for colorectal cancer (CRC) development. Hippo signaling pathway role have been investigated in CRC by regulating cell proliferation and apoptosis, however, the role of
Melika AmeliMojarad   +1 more
doaj   +1 more source

Monitoring alpha oscillations and pupil dilation across the performance-intensity function

open access: yesFrontiers in Psychology, 2016
Listening to degraded speech can be challenging and requires a continuous investment of cognitive resources, which is more challenging for those with hearing loss.
Catherine M McMahon   +14 more
doaj   +1 more source

Genomic prediction based on selected variants from imputed whole-genome sequence data in Australian sheep populations

open access: yesGenetics Selection Evolution, 2019
Background Whole-genome sequence (WGS) data could contain information on genetic variants at or in high linkage disequilibrium with causative mutations that underlie the genetic variation of polygenic traits.
Nasir Moghaddar   +8 more
doaj   +1 more source

LncRNA ES3 Is Upregulated in High-Grade CRC and Its Expression Is Elevated Along with Increasing Tumor Size [PDF]

open access: yesJournal of Genetic Resources, 2022
Cancer Stem Cell (CSC) is known as a minor percentage of tumor cells inside various malignancies with shared common features with embryonic stem cells such as self-renewal capability and pluripotency.
Mostafa Keshavarz, Malek Hossein Asadi
doaj   +1 more source

Апаратна реалізація модулів хешування на базі алгоритмів CRC-32 і Adler-32

open access: yesНауковий вісник Ужгородського університету. Серія: Математика і інформатика, 2021
У статті представлені результати дослідження хеш-функцій. Для досягнення оптимальної швидкодії та надійності захисту інформації обрана апаратна реалізація алгоритмів хешування.
А. О. Гедеон, О. М. Гапак
doaj   +1 more source

MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer

open access: yesCancer Biology & Therapy, 2023
Previous studies have indicated that miR-128 was downregulated in a variety of cancers including colorectal cancer (CRC). However, the role and the underlying molecular mechanisms of miR-128 in CRC still remain largely unknown.
Qingan Jia   +4 more
doaj   +1 more source

UCA1, a long noncoding RNA, promotes the proliferation of CRC cells via p53/p21 signaling

open access: yesOpen Life Sciences, 2016
Recently, the role of long noncoding RNAs (lncRNAs) in human colorectal cancer (CRC) has been a subject of intense focus. We set out to determine the function of one lncRNA, termed urothelial carcinoma-associated 1 (UCA1) in CRC cell proliferation and ...
Yi Shen   +5 more
doaj   +1 more source

A33 shows similar sensitivity to but is more specific than CDX2 as an immunomarker of colorectal carcinoma [PDF]

open access: yes, 2017
Aims: CDX2 is widely used as a sensitive and specific immunomarker for colorectal carcinoma (CRC) but neither this sensitivity nor specificity is absolute. This study is the first known comparison of CDX1 and A33 against CDX2 as immunomarkers for CRC.
Adamczyk, Lukasz A.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy